We are live on ! Find out more
DARE icon

Dare Bioscience
DARE

35 hedge funds and large institutions have $2.04M invested in Dare Bioscience in 2023 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 11 increasing their positions, 4 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

175% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 4

150% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 4

17% more funds holding

Funds holding: 30 → 35 (+5)

0.66% less ownership

Funds ownership: 1.22% → 0.56% (-0.66%)

66% less capital invested

Capital invested by funds: $5.97M → $2.04M (-$3.93M)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
35
Holders Change
+5
Holders Change %
+16.67%
% of All Funds
0.51%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
10
Increased
11
Reduced
4
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Geode Capital Management
Geode Capital Management
Massachusetts
+$58.3K
2
Renaissance Technologies
Renaissance Technologies
New York
+$18.5K
3
HighTower Advisors
HighTower Advisors
Illinois
+$13.7K
4
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services
Minnesota
+$11.8K
5
Northern Trust
Northern Trust
Illinois
+$8.37K

Top Sellers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
-$2.99M
2
Citadel Advisors
Citadel Advisors
Florida
-$61.1K
3
Jane Street
Jane Street
New York
-$11.5K
4
TSS
Two Sigma Securities
New York
-$10.8K
5
Commonwealth Equity Services
Commonwealth Equity Services
Massachusetts
-$6.36K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$1.07M +$1.5K +328 +0.1%
Geode Capital Management
2
Geode Capital Management
Massachusetts
$300K +$58.3K +12,762 +19%
Renaissance Technologies
3
Renaissance Technologies
New York
$222K +$18.5K +4,050 +7%
BlackRock
4
BlackRock
New York
$124K -$896 -196 -0.6%
State Street
5
State Street
Massachusetts
$76.5K – – –
Northern Trust
6
Northern Trust
Illinois
$56.6K +$8.37K +1,832 +14%
T. Rowe Price Associates
7
T. Rowe Price Associates
Maryland
$39K – – –
FFS
8
Founders Financial Securities
Maryland
$38.3K – – –
HighTower Advisors
9
HighTower Advisors
Illinois
$14K +$13.7K +3,000 +336%
VH
10
Visionary Horizons
Tennessee
$11.5K +$14.2K +3,104 New
Commonwealth Equity Services
11
Commonwealth Equity Services
Massachusetts
$10K -$6.36K -1,392 -34%
Wealth Enhancement Advisory Services
12
Wealth Enhancement Advisory Services
Minnesota
$9.54K +$11.8K +2,573 New
Charles Schwab
13
Charles Schwab
California
$9.43K – – –
RJFSA
14
Raymond James Financial Services Advisors
Florida
$8.53K +$2.89K +632 +38%
Bank of New York Mellon
15
Bank of New York Mellon
New York
$8.33K +$1.53K +334 +17%
TRCT
16
Tower Research Capital (TRC)
New York
$7.89K +$1.94K +425 +25%
ZIG
17
Zuckerman Investment Group
Illinois
$7.13K – – –
ASN
18
Advisory Services Network
Georgia
$4.63K – – –
VF
19
Virtu Financial
New York
$4K +$5.36K +1,172 New
JP Morgan Chase
20
JP Morgan Chase
New York
$3.8K +$4.64K +1,016 +11,289%
IA
21
IFS Advisors
Kansas
$3.52K – – –
FAFN
22
First Affirmative Financial Network
Colorado
$3.43K +$4.23K +925 New
FPF
23
First Pacific Financial
Washington
$3.09K +$3.81K +833 New
OS
24
Objectivity Squared
South Carolina
$3.09K +$3.81K +833 New
UBS Group
25
UBS Group
Switzerland
$2.66K +$3.08K +675 +1,607%
1
2

DARE Hedge Fund Activity: Q4 2023 in Review

35 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Dare Bioscience (DARE) for Q4 2023, worth a combined $2.04M — down 66% from $5.97M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new DARE positions and 4 closed out — a net gain of 6 holders — while 11 added to existing stakes and 4 trimmed.

The largest buyer was Geode Capital Management, adding an estimated $58.3K. The largest seller was Armistice Capital, exiting entirely with an estimated $2.99M sold.

  • 35 institutional investors held Dare Bioscience (DARE) as of Q4 2023, up from 30 in Q3 2023.
  • Funds reported $2.04M of Dare Bioscience stock for Q4 2023, down 66% quarter-over-quarter.
  • 10 funds opened new Dare Bioscience positions in Q4 2023 and 4 closed out, a net change of +6 holders.
  • The largest Dare Bioscience buyer in Q4 2023 was Geode Capital Management, an estimated $58.3K added.
  • The largest Dare Bioscience seller in Q4 2023 was Armistice Capital, an estimated $2.99M sold.

Based on aggregated 13F filings for Q4 2023.